MurciaSalud
9
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
11%
1 trials in Phase 3/4
11%
1 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Impact of a PERsonalized CAse MAnagement Program for the Follow-up of Moderate and Severe aSTHma Patients on Exacerbations, Health Resource Use and Asthma Control: PERCASTHMA STUDY
Role: lead
Efficacy of the Otago Exercise Program Delivered as Group Training Versus Individually Tailored Training
Role: collaborator
Consequences of Doing What Should Not be Done in Primary Care
Role: collaborator
Effectiveness of Non-pharmacological Interventions in Patients With Cardiovascular Risk Factors in Primary Care
Role: collaborator
Effectiveness of the Spirometry Test as a Motivational Tool for Quitting Tobacco in Primary Care
Role: collaborator
Educational Intervention for Managing Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Patients
Role: collaborator
Prevalence of Undiagnosed Chronic Obstructive Pulmonary Disease Sufferers in the Region of Murcia
Role: collaborator
Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)
Role: lead
Use of the Amniotic Membrane in Large Wound Epithelialization
Role: collaborator
All 9 trials loaded